Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells

Zhou,Gang; Yang,Jing; Song,Peng

doi:10.3892/ol.2018.9857

Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells

Authors:
- Gang Zhou
- Jing Yang
- Peng Song
View Affiliations

Affiliations: Department of Medical Oncology, The Second Medical Centre, Chinese PLA General Hospital, Beijing 100853, P.R. China
Published online on: December 20, 2018 https://doi.org/10.3892/ol.2018.9857
Pages: 2266-2270
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The role of extracellular signal‑regulated kinase/mitogen‑activated protein kinase (ERK/MAPK) signaling pathway in the proliferation and apoptosis of human colon cancer cells was studied. The transduction process of ERK/MAPK signaling pathway was inhibited using methyl ethyl ketone (MEK) inhibitor U0126. Promoting effect of hepatocyte growth factor (HGF) on proliferation of human colon cancer cells was detected via Cell Counting Kit 8 (CCK8), the cycle and apoptosis of human colon cancer cells were detected via flow cytometry, and the migration of human colon cancer cells was detected via wound healing assay. The results revealed that after drug treatment for 48 h, there were statistically significant differences in 4 and 8 µmol/l U0126 experimental group compared with control group (P<0.05). Compared with those in control group, G1 phase, S phase, G2 phase and proliferation index (PI) in 2, 4 and 8 µmol/l U0126 group had statistically significant differences (P<0.05). There were statistically significant differences in comparison of G1 phase, S phase, G2 phase and PI between control and 8 µmol/l U0126 group (P<0.05). Compared with that in control group, the cell migration distance in 8 µmol/l U0126 group had a statistically significant difference after drug treatment for 24 h (P<0.05). After drug treatment for 48 and 72 h, the cell migration distance in 4 and 8 µmol/l U0126 group was significantly reduced, and the differences were statistically significant compared with that in control group (P<0.05). In conclusion, ERK/MAPK signaling pathway is involved in the effects of HGF of promoting proliferation and regulating cell cycle and apoptosis of human colon cancer cells, providing a new approach for the treatment of colon cancer.

View Figures

View References

1	Chen Y, Xie H, Gao Q, Zhan H, Xiao H, Zou Y, Zhang F, Liu Y and Li J: Colon cancer associated transcripts in human cancers. Biomed Pharmacother. 94:531–540. 2017. View Article : Google Scholar : PubMed/NCBI
2	Tahir AA, Sani NF, Murad NA, Makpol S, Ngah WZ and Yusof YA: Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells. Nutr J. 14:312015. View Article : Google Scholar : PubMed/NCBI
3	Ye J, Talaiti A, Ma Y, Zhang Q, Ma L and Zheng H: Allergies and risk of colorectal cancer: A systematic review and meta-analysis of observational studies. Oncotarget. 8:14646–14654. 2017.PubMed/NCBI
4	Setia S, Nehru B and Sanyal SN: Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer. Biomed Pharmacother. 68:1023–1029. 2014. View Article : Google Scholar : PubMed/NCBI
5	Zhang Y, Yuan J, Zhang X, Yan F, Huang M, Wang T, Zheng X and Zhang M: Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway. Oncol Rep. 36:3619–3626. 2016. View Article : Google Scholar : PubMed/NCBI
6	Urosevic J, Nebreda AR and Gomis RR: MAPK signaling control of colon cancer metastasis. Cell Cycle. 13:2641–2642. 2014. View Article : Google Scholar : PubMed/NCBI
7	Dziegielewska B, Brautigan DL, Larner JM and Dziegielewski J: T-type Ca²⁺ channel inhibition induces p53-dependent cell growth arrest and apoptosis through activation of p38-MAPK in colon cancer cells. Mol Cancer Res. 12:348–358. 2014. View Article : Google Scholar : PubMed/NCBI
8	Zuo L, Yang X, Lu M, Hu R, Zhu H, Zhang S, Zhou Q, Chen F, Gui S and Wang Y: All-trans retinoic acid inhibits human colorectal cancer cells RKO migration via downregulating myosin light chain kinase expression through MAPK signaling pathway. Nutr Cancer. 68:1225–1233. 2016. View Article : Google Scholar : PubMed/NCBI
9	Gröschl B, Bettstetter M, Giedl C, Woenckhaus M, Edmonston T, Hofstädter F and Dietmaier W: Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Int J Cancer. 132:1537–1546. 2013. View Article : Google Scholar : PubMed/NCBI
10	Randhawa H, Kibble K, Zeng H, Moyer MP and Reindl KM: Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol In Vitro. 27:1626–1633. 2013. View Article : Google Scholar : PubMed/NCBI
11	Mao JD, Wu P, Huang JX, Wu J and Yang G: Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma. World J Gastroenterol. 20:12542–12550. 2014. View Article : Google Scholar : PubMed/NCBI
12	Zhao Y, Fan D, Zheng ZP, Li ET, Chen F, Cheng KW and Wang M: 8-C-(E-phenylethenyl)quercetin from onion/beef soup induces autophagic cell death in colon cancer cells through ERK activation. Mol Nutr Food Res. 61:16004372017. View Article : Google Scholar
13	Radziwon-Balicka A, Santos-Martinez MJ, Corbalan JJ, O'Sullivan S, Treumann A, Gilmer JF, Radomski MW and Medina C: Mechanisms of platelet-stimulated colon cancer invasion: Role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway. Carcinogenesis. 35:324–332. 2014. View Article : Google Scholar : PubMed/NCBI
14	Lee M, Young Kim S, Kim J, Kim HS, Kim SM and Kim EJ: Mitogen-activated protein kinase phosphatase-1 inhibition and sustained extracellular signal-regulated kinase 1/2 activation in camptothecin-induced human colon cancer cell death. Cancer Biol Ther. 14:1007–1015. 2013. View Article : Google Scholar : PubMed/NCBI
15	Slattery ML, Lundgreen A and Wolff RK: Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer. 65:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
16	Enayat S, Ceyhan MŞ, Başaran AA, Gürsel M and Banerjee S: Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: Involvement of Akt/PKB and MAPK pathways. Nutr Cancer. 65:1045–1058. 2013. View Article : Google Scholar : PubMed/NCBI
17	Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, Zhang P, Zhu H, Xu N and Liang S: STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 7:71400–71416. 2016.PubMed/NCBI
18	Bodur C, Kutuk O, Karsli-Uzunbas G, Isimjan TT, Harrison P and Basaga H: Pramanicin analog induces apoptosis in human colon cancer cells: Critical roles for Bcl-2, Bim, and p38 MAPK signaling. PLoS One. 8:e563692013. View Article : Google Scholar : PubMed/NCBI
19	Zhang P, Kawakami H, Liu W, Zeng X, Strebhardt K, Tao K, Huang S and Sinicrope FA: Targeting CDK1 and MEK/ERK overcomes apoptotic resistance in BRAF-mutant human colorectal cancer. Mol Cancer Res. 16:378–389. 2018. View Article : Google Scholar : PubMed/NCBI
20	Najar AG, Pashaei-Asl R, Omidi Y, Farajnia S and Nourazarian AR: EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line. Asian Pac J Cancer Prev. 14:495–498. 2013. View Article : Google Scholar : PubMed/NCBI